.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeMarket Insights Snapshot
In October 2026, Glacial Gold’s category mix is concentrated in Capsules at 70.37% share with 118.60% year-over-year growth and 17.33% month-over-month growth, while Vapor Pens hold 15.31% share with 83.24% year-over-year and 19.68% month-over-month growth. Oil accounts for 14.28% share with 34.58% year-over-year and 16.45% month-over-month growth, and Pre-Roll has contracted to 0.05% share with -94.24% year-over-year and -79.04% month-over-month decline. The overall brand experienced 92.51% year-over-year sales growth alongside a 1.96% year-over-year increase in average price to $37.29, and Glacial Gold holds rank 1 in Capsules in Alberta. The pattern implies a deepening specialization in Capsules, with Vapor Pens and Oil scaling as secondary pillars while Pre-Roll is being de-emphasized.
The shift toward Capsules at 70.37% share combined with rank 1 in Capsules in Alberta and double-digit month-over-month gains in Capsules (17.33%) and Vapor Pens (19.68%) indicates a strategy anchored in dose-controlled formats, supported by adjacent inhalable formats for acquisition and trade-up. With Vapor Pens growing faster month-over-month than Capsules by 2.35 percentage points and Oil expanding 16.45% month-over-month despite a lower 34.58% year-over-year rate, the portfolio is tilting toward higher-velocity, mid-priced formats while maintaining premium Capsules pricing at $40.05 versus a brand average of $37.29. This implies Glacial Gold’s near-term positioning is to defend category leadership in Capsules while using Vapor Pens’ and Oil’s accelerating month-over-month momentum to diversify revenue without diluting the Capsules-first identity.
Competitive Landscape
Glacial Gold is ranked #1 in BC Capsules in October 2026, unchanged from #1 in October 2025, and it also held #1 three months ago, implying zero rank volatility while maintaining peak position in October 2026; meanwhile, Emprise Canada holds #2 year over year and currently, despite 100.3% YoY sales growth, and Rosin Heads advanced from #7 to #4 with 133.6% YoY sales growth, narrowing the mid-tier gap. This mix of flat rank at #1 for Glacial Gold alongside a #2 that did not improve and a #7-to-#4 climber indicates that leadership is steady now, but accelerating contenders are compressing the field and raise the likelihood of rank pressure if momentum persists.
Notable Products
Glacial Gold’s October 2026 sales are tightly concentrated, with the top 10 items accounting for 76.3% of revenue and the leading softgel holding 19.6%. Capsules dominate the mix at 70.4% across CBD/CBN and Hybrid segments, so most of its sales come from softgels.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
